Article
The effectiveness and value of novel treatments for cystic fibrosis.
Journal of managed care & specialty pharmacy - 1 Feb 2021
Tice Jeffrey A, Kuntz Karen M, Wherry Kael, Seidner Matt, Rind David M, Pearson Steven D
Abstract excerpt
DISCLOSURES: Funding for this summary was contributed by Arnold Ventures, California Health Care Foundation, Harvard Pilgrim Health Care, and Kaiser Foundation Health Plan to the Institute for Clinical and Economic Review (ICER), an independent organization that evaluates the evidence on the value of health care interventions. ICER's annual policy summit is supported by dues from Aetna, America's Health Insurance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
